Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Vaccine: X|April 24, 2024
Landscape review of active vaccine safety surveillance activities for COVID-19 vaccines globallyParisa A ShamaeiZadeh, Carmen Villamizar Jaimes, Maria Deloria Knoll, et al.
Drug Safety|September 18, 2016
Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®Rebecca E Chandler, Kristina Juhlin, Jonas Fransson, et al.
Vaccine|August 10, 2023
Benefit-risk assessment of vaccinesSonali Kochhar, Hector S Izurieta, Rebecca E Chandler, et al.
Drug Safety|July 4, 2020
Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High ReportingEiko Iwasa, Yu Fujiyoshi, Yuki Kubota, et al.
Drug Safety|September 22, 2017
Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring CentreSarah Watson, Rebecca E Chandler, Henric Taavola, et al.
Drug Safety|November 27, 2025
Systematic Review of Active Safety Surveillance of Vaccines and Medicines in Low- and Middle-Income CountriesAndy Stergachis, Esperança Sevene, Mohammad Gazi Shah Alam, et al.
BMJ Global Health|March 7, 2024
Collaboration within the global vaccine safety surveillance ecosystem during the COVID-19 pandemic: lessons learnt and key recommendations from the COVAX Vaccine Safety Working GroupRebecca E Chandler, Madhava Ram Balakrishnan, Daniel Brasseur, et al.
Vaccine|February 28, 2021
Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety dataTiphanie P Vogel, Karina A Top, Christos Karatzios, et al.
Drug Safety|April 13, 2025
Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of PharmacovigilanceSalvatore Crisafulli, Andrew Bate, Jeffrey Stuart Brown, et al.
Vaccine|April 30, 2023
Considerations for unblinding individual study participants during vaccine trialsNeal Halsey, Stephen Evans, Mathuram Santosham, et al.
Pageof 2